AstraZeneca Pharma India per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹67.85₹75.01₹46.30₹64.60₹39.72
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹34.73₹0.00₹46.30₹64.60₹39.72
₹349.12₹349.12₹308.14₹284.77₹235.48
₹972.82₹910.23₹686.52₹518.21₹401.19
—−₹6.06₹26.14₹37.01₹23.32
−₹7.50−₹7.50₹25.44₹32.71₹19.91
—₹32.00₹24.00₹16.00₹8.00
2.52.52.52.52.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ASTRAZEN₹6,237.00

AstraZeneca Pharma India Limited

· Pharma & Health
₹ CrorePeersSANOFICONRPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCMcap ₹15,593 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS39.7264.6046.3075.0167.85
Diluted EPS39.7264.6046.300.0034.73
Book Value per Share235.48284.77308.14349.12349.12
Revenue per Share401.19518.21686.52910.23972.82
Cash Flow per Share23.3237.0126.14-6.06—
Free Cash Flow per Share19.9132.7125.44-7.50-7.50
Dividends per Share8.0016.0024.0032.00—
Shares Outstanding (cr)2.52.52.52.52.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.